Using retroviral vectors to express SV40 tumor antigens.
Cherington
V
V
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA, USA.
Higgins
C
C
D016475:3T3 Cells; D000818:Animals; D000952:Antigens, Polyomavirus Transforming / Q000032:analysis / Q000096:biosynthesis / Q000235:genetics*; D002448:Cell Adhesion; D002460:Cell Line; D004591:Electrophoresis, Polyacrylamide Gel; D015870:Gene Expression; D005822:Genetic Vectors; D006801:Humans; D015151:Immunoblotting / Q000379:methods; D007150:Immunohistochemistry / Q000379:methods; D051379:Mice; D010957:Plasmids / Q000235:genetics; D011994:Recombinant Proteins / Q000032:analysis / Q000096:biosynthesis / Q000235:genetics; D012190:Retroviridae / Q000235:genetics* / Q000502:physiology; D013539:Simian virus 40 / Q000235:genetics* / Q000276:immunology*; D014161:Transduction, Genetic; D014162:Transfection; D014721:Vesicular stomatitis Indiana virus / Q000235:genetics; D014773:Virology / Q000379:methods*; D014779:Virus Replication
D000952:Antigens, Polyomavirus Transforming; D011994:Recombinant Proteins